MarkWide Research

Sale!

Surrogacy Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Surrogacy Market size exceeded USD 4 billion in 2020 and is projected to achieve over 32.6% CAGR between 2021 and 2027.
Surrogacy is a reproduction procedure wherein an arrangement is made for a surrogate to bear a child for intended parents. The procedure is legally backed. Surrogacy can be conducted traditionally or by gestational means. It has not been yet approved in all countries and the regulatory scenario is evolving with the passage of time. Recently, government of few countries including India have passed laws to allow surrogacy to help widows and divorced women apart from infertile homogenous and heterogenous couples. Such regulations coupled with growing awareness about availability of advanced reproductive technologies and alternatives will stimulate the global market growth during the forecast period.
COVID-19 pandemic hampered the overall number of surrogacies throughout the globe due to restrictions on non-emergency procedures. Couples who had started the cycle early in 2020 were not affected, however, new aspiring couples were quite affected owing to deferrals. With reduction in patient burden subsequently, the procedures regained traction and the surrogacy market is expected to momentously grow over the forecast period.

Growing burden of infertility attributed to the changing demographics will spur adoption of surrogacy

Rapidly increasing number of working women in emerging economies has shifted the childbearing age ahead. Progressing age along with several lifestyle changes negatively impacts fertility among women as well as men. In addition, habits such as alcoholism, smoking and consumption of calorie-rich diet affect fertility. With such faltering lifestyle, the ability to bear child is reducing, thereby increasing the prevalence of infertility.
Increasing inability to conceive has compelled reproductive medicine to advance in order to present several alternatives including surrogacy to support couples in having children. Sophisticated approaches including in-vitro fertilization, which has substantial success rate, have penetrated the market and are being rapidly adopted by numerous aspiring parents. Thus, market will foresee robust growth in the coming years. However, high cost of treatment in developed nations, especially in the U.S., can hinder the demand up to some extent.

Higher preference for gestational surrogacy will influence the segment growth

Gestational surrogacy being the most common type has gained significant demand in recent years. In gestational surrogacy procedure, the new-born is completely associated with the intended parent(s) genetically. The overall procedure is less complicated than traditional surrogacy. Gestational surrogacy has a proven greater success rate and will thus witness considerable growth in the coming years.

Superlative outcomes with in-vitro fertilization (IVF) procedure will enhance the segment expansion

IVF segment dominated more than 62% of the surrogacy market share in 2020. This technique of treating fertility is advanced and has higher success rate, leading to singleton or multiple pregnancies.
Various advances have been made in the IVF procedure including introduction of IVF with intracytoplasmic sperm injection (ICSI). IVF with ICSI is chiefly adopted in treatment of males having severe infertility issues. This technique has a success rate that ranges from 50 to 85%. With such high potential, the overall IVF market will foresee robust demand during the forecast timeline.

Greater chances of conceiving among women aged below 35 years will positively impact the segment progression

Below 35 years segment is poised to observe 33.2% growth rate through 2027. As per guidelines by the American Society for Reproductive Medicine (ASRM), an ideal surrogate must be a healthy woman preferably aged between 21 years and 35 years. Surrogacy carriers aged younger are a superior fit as fertility declines significantly after 30 years of age among women.

Growing investment in expansion of fertility clinics will augment their revenue growth

Fertility clinics segment was valued at USD 2.5 billion in 2020. Laws and regulations passed in favour of surrogacy have attracted stakeholders to invest in fertility centres and clinics. Clinics have improved their infrastructure along with fortification of portfolio including surrogacy services. This has increased the accessibility to the target population, thereby impelling the customer base and business size.

Availability of cost-effective surrogacy in Europe will propel the market revenue

Europe surrogacy market captured over 42% of revenue share in 2020. Various countries in the European region have permitted surrogacy procedures including Czech Republic, Greece, Russia, UK, Estonia, Greece and Georgia among few others. These countries have well-established infrastructure to conduct advanced technology-based procedures. People from some developed countries wherein surrogacy is expensive, seek treatment in such European countries due to cost-effectivity. Nations such as Estonia and Greece offer relatively affordable treatment, thereby increasing customer preference.

Acquisitions and facility expansion strategies are the being chiefly adopted by service providers to encash maximum growth opportunities

The global market consists of numerous players operating at regional and country-level including fertility clinics and hospitals. Few of the companies involved are IVIRMA, Circle Surrogacy, Nova and New Hope Fertility Clinic among various others. These providers are undertaking business growth strategies to broaden their market footprint.

Some of the recent industry developments:

  • In January 2021, Triangle Capital Corporation announced its acquisition of Bourn Hall Ltd., a British fertility clinic. The acquisition will help the company in enhancing reach to its customers and offer business expansion opportunities.
  • In September 2020, Inception Fertility introduced Pathways Fertility, a new network of clinics in Georgia. The new clinic, Pathways, offers services to couples with latest technology in reproductive medicine at affordable cost, thereby fostering their client base.

The surrogacy market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Type

  • Gestational surrogacy
  • Traditional surrogacy

Market, By technology

  • Intrauterine insemination (IUI)
  • In-vitro fertilization (IVF)
    • Classical/standard IVF
    • Intracytoplasmic sperm injection (ICSI)
  • Others

Market, By Age Group

  • Below 35 years
  • 35-37 years
  • 38 – 39 years
  • 40-42 years
  • 43-44 years
  • Over 44 years

Market, By Service Provider

  • Hospitals
  • Fertility clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Others
  • Europe
    • Czech Republic
    • Estonia
    • Georgia
    • Greece
    • Poland
    • Russia
    • Sweden
    • Ukraine
    • UK
  • Asia Pacific
    • India
    • Thailand
    • South Korea
  • Africa
    • Kenya
    • Nigeria
    • South Africa

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Africa

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Surrogacy industry 3600 synopsis

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Technology trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Surrogacy Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing number of infertility cases globally

3.3.1.2    Rising awareness about the infertility treatment options available in the market

3.3.1.3    Growing prevalence of causative factors including hormonal changes, alcohol consumption and others leading to infertility issues

3.3.1.4    Increasing number of fertility clinics

3.3.2    Industry pitfalls and challenges

3.3.2.1    Stringent regulations pertaining commercial surrogacy

3.3.2.2    High cost involved in surrogacy procedure

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By technology

3.4.3    By age group

3.4.4    By service provider

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Procedure trend

3.8    Porter’s analysis

3.9    Competitive landscape, 2020

3.10    PESTEL analysis

Chapter 4   Surrogacy Market, By Type

4.1    Key segment trends

4.2    Gestational surrogacy

4.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.3    Traditional surrogacy

4.3.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 5   Surrogacy Market, By Technology

5.1    Key segment trends

5.2    Intrauterine insemination (IUI)

5.2.1    Market size, by region, 2016 – 2027 (USD Million)

5.3    In-vitro fertilization (IVF)

5.3.1    Market size, by region, 2016 – 2027 (USD Million)

5.3.2    Classical/standard IVF

5.3.2.1    Market size, by region, 2016 – 2027 (USD Million)

5.3.3    Intracytoplasmic sperm injection (ICSI)

5.3.3.1    Market size, by region, 2016 – 2027 (USD Million)

5.4    Others

5.4.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 6   Surrogacy Market, By Age Group

6.1    Key segment trends

6.2    Below 35 years

6.2.1    Market size, by region, 2016 – 2027 (USD Million)

6.3    35-37 years

6.3.1    Market size, by region, 2016 – 2027 (USD Million)

6.4    38 – 39 years

6.4.1    Market size, by region, 2016 – 2027 (USD Million)

6.5    40-42 years

6.5.1    Market size, by region, 2016 – 2027 (USD Million)

6.6    43-44 years

6.6.1    Market size, by region, 2016 – 2027 (USD Million)

6.7    Over 44 years

6.7.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 7   Surrogacy Market, By Service Provider

7.1    Key segment trends

7.2    Hospitals

7.2.1    Market size, by region, 2016 – 2027 (USD Million)

7.3    Fertility clinics

7.3.1    Market size, by region, 2016 – 2027 (USD Million)

7.4    Others

7.4.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 8   Surrogacy Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2016 – 2027 (USD Mn)

8.2.2    Market size, by type, 2016 – 2027 (USD Mn)

8.2.3    Market size, by technology, 2016 – 2027 (USD Mn)

8.2.3.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.2.4    Market size, by age group, 2016 – 2027 (USD Mn)

8.2.5    Market size, by service provider, 2016 – 2027 (USD Mn)

8.2.6    U.S.

8.2.6.1    Market size, by type, 2016 – 2027 (USD Mn)

8.2.6.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.2.6.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.2.6.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.2.6.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.2.7    Others

8.2.7.1    Market size, by type, 2016 – 2027 (USD Mn)

8.2.7.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.2.7.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.2.7.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.2.7.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3    Europe

8.3.1    Market size, by country, 2016 – 2027 (USD Mn)

8.3.2    Market size, by type, 2016 – 2027 (USD Mn)

8.3.3    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.3.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.4    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.5    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.6    Czech Republic

8.3.6.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.6.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.6.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.6.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.6.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.7    Estonia

8.3.7.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.7.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.7.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.7.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.7.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.8    Georgia

8.3.8.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.8.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.8.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.8.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.8.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.9    Greece

8.3.9.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.9.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.9.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.9.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.9.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.10    Poland

8.3.10.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.10.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.10.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.10.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.10.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.11    Russia

8.3.11.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.11.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.11.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.11.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.11.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.12    Sweden

8.3.12.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.12.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.12.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.12.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.12.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.13    Ukraine

8.3.13.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.13.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.13.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.13.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.13.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.3.14    UK

8.3.14.1    Market size, by type, 2016 – 2027 (USD Mn)

8.3.14.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.3.14.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.3.14.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.3.14.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.4    Asia Pacific

8.4.1    Market size, by country, 2016 – 2027 (USD Mn)

8.4.2    Market size, by type, 2016 – 2027 (USD Mn)

8.4.3    Market size, by technology, 2016 – 2027 (USD Mn)

8.4.3.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.4.4    Market size, by age group, 2016 – 2027 (USD Mn)

8.4.5    Market size, by service provider, 2016 – 2027 (USD Mn)

8.4.6    India

8.4.6.1    Market size, by type, 2016 – 2027 (USD Mn)

8.4.6.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.4.6.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.4.6.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.4.6.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.4.7    Thailand

8.4.7.1    Market size, by type, 2016 – 2027 (USD Mn)

8.4.7.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.4.7.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.4.7.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.4.7.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.4.8    South Korea

8.4.8.1    Market size, by type, 2016 – 2027 (USD Mn)

8.4.8.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.4.8.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.4.8.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.4.8.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.5    Africa

8.5.1    Market size, by country, 2016 – 2027 (USD Mn)

8.5.2    Market size, by type, 2016 – 2027 (USD Mn)

8.5.3    Market size, by technology, 2016 – 2027 (USD Mn)

8.5.3.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.5.4    Market size, by age group, 2016 – 2027 (USD Mn)

8.5.5    Market size, by service provider, 2016 – 2027 (USD Mn)

8.5.6    South Africa

8.5.6.1    Market size, by type, 2016 – 2027 (USD Mn)

8.5.6.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.5.6.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.5.6.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.5.6.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.5.7    Kenya

8.5.7.1    Market size, by type, 2016 – 2027 (USD Mn)

8.5.7.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.5.7.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.5.7.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.5.7.4    Market size, by service provider, 2016 – 2027 (USD Mn)

8.5.8    Nigeria

8.5.8.1    Market size, by type, 2016 – 2027 (USD Mn)

8.5.8.2    Market size, by technology, 2016 – 2027 (USD Mn)

8.5.8.2.1    Market size, by in-vitro fertilization (IVF), 2016 – 2027 (USD Mn)

8.5.8.3    Market size, by age group, 2016 – 2027 (USD Mn)

8.5.8.4    Market size, by service provider, 2016 – 2027 (USD Mn)

Chapter 9   Company Profiles

9.1    Competitive dashboard, 2020

9.2    Bangkok IVF Centre

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Bourn Hall International

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    Inception Fertility

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    Circle Surrogacy

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Clinic Scanfert

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Growing Generations, LLC

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    IVIRMA

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    Morpheus Life Sciences Pvt Ltd

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    New Hope Fertility Clinic

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Nova

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis

9.12    Ovation Fertility

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.12.5    SWOT analysis

9.13    Extraordinary Conceptions

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook

9.13.5    SWOT analysis

9.14    MAX HEALTHCARE

9.14.1    Business overview

9.14.2    Financial data

9.14.3    Product landscape

9.14.4    Strategic outlook

9.14.5    SWOT analysis

Data Tables

TABLE 1.    Surrogacy market, 2016 – 2020 (USD Million)

TABLE 2.    Surrogacy industry 3600 synopsis, 2014 – 2025

TABLE 3.    Global surrogacy market size, 2014 – 2018, (USD Million)

TABLE 4.    Global surrogacy market size, 2019 – 2025, (USD Million)

TABLE 5.    Global surrogacy market size, by type, 2014 – 2018 (USD Million)

TABLE 6.    Global surrogacy market size, by type, 2019 – 2025 (USD Million)

TABLE 7.    Global surrogacy market size, by technology, 2014 – 2018 (USD Million)

TABLE 8.    Global surrogacy market size, by technology, 2019 – 2025 (USD Million)

TABLE 9.    Global surrogacy market size, by age group, 2014 – 2018 (USD Million)

TABLE 10.    Global surrogacy market size, by age group, 2019 – 2025 (USD Million)

TABLE 11.    Global surrogacy market size, by service provider, 2014 – 2018 (USD Million)

TABLE 12.    Global surrogacy market size, by service provider, 2019 – 2025 (USD Million)

TABLE 13.    Global surrogacy market size, by region, 2014 – 2018 (USD Million)

TABLE 14.    Industry impact forces

TABLE 15.    Gestational surrogacy market size, by region, 2014 – 2018, (USD Million)

TABLE 16.    Gestational surrogacy market size, by region, 2019 – 2025, (USD Million)

TABLE 17.    Traditional surrogacy market size, by region, 2014 – 2018, (USD Million)

TABLE 18.    Traditional surrogacy market size, by region, 2019 – 2025, (USD Million)

TABLE 19.    Intrauterine insemination market size, by region, 2014 – 2018, (USD Million)

TABLE 20.    Intrauterine insemination market size, by region, 2019 – 2025, (USD Million)

TABLE 21.    In-vitro fertilization market size, by region, 2014 – 2018, (USD Million)

TABLE 22.    In-vitro fertilization market size, by region, 2019 – 2025, (USD Million)

TABLE 23.    Classical/standard IVF market size, by in-vitro fertilization, 2014 – 2018, (USD Million)

TABLE 24.    Classical/standard IVF market size, by in-vitro fertilization, 2019 – 2025, (USD Million)

TABLE 25.    Intracytoplasmic sperm injection market size, by in-vitro fertilization, 2014 – 2018, (USD Million)

TABLE 26.    Intracytoplasmic sperm injection market size, by in-vitro fertilization, 2019 – 2025, (USD Million)

TABLE 27.    Others market size, by region, 2014 – 2018, (USD Million)

TABLE 28.    Others market size, by region, 2019 – 2025, (USD Million)

TABLE 29.    Below 35 years market size, by region, 2014 – 2018, (USD Million)

TABLE 30.    Below 35 years market size, by region, 2019 – 2025, (USD Million)

TABLE 31.    35-37 years market size, by region, 2014 – 2018, (USD Million)

TABLE 32.    35-37 years market size, by region, 2019 – 2025, (USD Million)

TABLE 33.    38 – 39 years market size, by region, 2014 – 2018, (USD Million)

TABLE 34.    38 – 39 years market size, by region, 2019 – 2025, (USD Million)

TABLE 35.    40-42 years market size, by region, 2014 – 2018, (USD Million)

TABLE 36.    40-42 years market size, by region, 2019 – 2025, (USD Million)

TABLE 37.    43-44 years market size, by region, 2014 – 2018, (USD Million)

TABLE 38.    43-44 years market size, by region, 2019 – 2025, (USD Million)

TABLE 39.    Over 44 years market size, by region, 2014 – 2018, (USD Million)

TABLE 40.    Over 44 years market size, by region, 2019 – 2025, (USD Million)

TABLE 41.    Hospitals market size, by region, 2014 – 2018, (USD Million)

TABLE 42.    Hospitals market size, by region, 2019 – 2025, (USD Million)

TABLE 43.    Fertility clinics centers market size, by region, 2014 – 2018, (USD Million)

TABLE 44.    Fertility clinics centers market size, by region, 2019 – 2025, (USD Million)

TABLE 45.    Others market size, by region, 2014 – 2018, (USD Million)

TABLE 46.    Others market size, by region, 2019 – 2025, (USD Million)

TABLE 47.    North America surrogacy market size, by country, 2014 – 2018 (USD Million)

TABLE 48.    North America surrogacy market size, by country, 2019 – 2025 (USD Million)

TABLE 49.    North America surrogacy market size, by type, 2014 – 2018 (USD Million)

TABLE 50.    North America surrogacy market size, by type, 2019 – 2025 (USD Million)

TABLE 51.    North America surrogacy market size, by technology, 2014 – 2018 (USD Million)

TABLE 52.    North America surrogacy market size, by technology, 2019 – 2025 (USD Million)

TABLE 53.    North America surrogacy market size, by in-vitro fertilization, 2014 – 2018 (USD Million)

TABLE 54.    North America surrogacy market size, by in-vitro fertilization, 2019 – 2025 (USD Million)

TABLE 55.    North America surrogacy market size, by age group, 2014 – 2018 (USD Million)

TABLE 56.    North America surrogacy market size, by age group, 2019 – 2025 (USD Million)

TABLE 57.    North America surrogacy market size, by service provider, 2014 – 2018 (USD Million)

TABLE 58.    North America surrogacy market size, by service provider, 2019 – 2025 (USD Million)

TABLE 59.    U.S. surrogacy market size, by type, 2014 – 2018 (USD Million)

TABLE 60.    U.S. surrogacy market size, by type, 2019 – 2025 (USD Million)

TABLE 61.    U.S. surrogacy market size, by technology, 2014 – 2018 (USD Million)

TABLE 62.    U.S. surrogacy market size, by technology, 2019 – 2025 (USD Million)

TABLE 63.    U.S. surrogacy market size, by in-vitro fertilization, 2014 – 2018 (USD Million)

TABLE 64.    U.S. surrogacy market size, by in-vitro fertilization, 2019 – 2025 (USD Million)

TABLE 65.    U.S. surrogacy market size, by age group, 2014 – 2018 (USD Million)

TABLE 66.    U.S. surrogacy market size, by age group, 2019 – 2025 (USD Million)

TABLE 67.    U.S. surrogacy market size, by service provider, 2014 – 2018 (USD Million)

TABLE 68.    U.S. surrogacy market size, by service provider, 2019 – 2025 (USD Million)

TABLE 69.    Europe surrogacy market size, by country, 2014 – 2018 (USD Million)

TABLE 70.    Europe Surrogacy market size, by country, 2019 – 2025 (USD Million)

TABLE 71.    Europe surrogacy market size, by type, 2014 – 2018 (USD Million)

TABLE 72.    Europe surrogacy market size, by type, 2019 – 2025 (USD Million)

TABLE 73.    Europe surrogacy market size, by technology, 2014 – 2018 (USD Million)

TABLE 74.    Europe surrogacy market size, by technology, 2019 – 2025 (USD Million)

TABLE 75.    Europe surrogacy market size, by in-vitro fertilization, 2014 – 2018 (USD Million)

TABLE 76.    Europe surrogacy market size, by in-vitro fertilization, 2019 – 2025 (USD Million)

TABLE 77.    Europe surrogacy market size, by age group, 2014 – 2018 (USD Million)

TABLE 78.    Europe surrogacy market size, by age group, 2019 – 2025 (USD Million)

TABLE 79.    Europe surrogacy market size, by service provider, 2014 – 2018 (USD Million)

TABLE 80.    Europe surrogacy market size, by service provider, 2019 – 2025 (USD Million)

TABLE 81.    Czech Republic surrogacy market size, by type, 2014 – 2018 (USD Million)

TABLE 82.    Czech Republic surrogacy market size, by type, 2019 – 2025 (USD Million)

TABLE 83.    Czech Republic surrogacy market size, by technology, 2014 – 2018 (USD Million)

TABLE 84.    Czech Republic surrogacy market size, by technology, 2019 – 2025 (USD Million)

TABLE 85.    Czech Republic surrogacy market size, by in-vitro fertilization, 2014 – 2018 (USD Million)

TABLE 86.    Czech Republic surrogacy market size, by in-vitro fertilization, 2019 – 2025 (USD Million)

TABLE 87.    Czech Republic surrogacy market size, by age group, 2014 – 2018 (USD Million)

TABLE 88.    Czech Republic surrogacy market size, by age group, 2019 – 2025 (USD Million)

TABLE 89.    Czech Republic surrogacy market size, by service provider, 2014 – 2018 (USD Million)

TABLE 90.    Czech Republic surrogacy market size, by service provider, 2019 – 2025 (USD Million)

TABLE 91.    Estonia surrogacy market size, by type, 2014 – 2018 (USD Million)

TABLE 92.    Estonia surrogacy market size, by type, 2019 – 2025 (USD Million)

TABLE 93.    Estonia surrogacy market size, by technology, 2014 – 2018 (USD Million)

TABLE 94.    Estonia surrogacy market size, by technology, 2019 – 2025 (USD Million)

TABLE 95.    Estonia surrogacy market size, by in-vitro fertilization, 2014 – 2018 (USD Million)

TABLE 96.    Estonia surrogacy market size, by in-vitro fertilization, 2019 – 2025 (USD Million)

TABLE 97.    Estonia surrogacy market size, by age group, 2014 – 20

Market, By Type

  • Gestational surrogacy
  • Traditional surrogacy

Market, By technology

  • Intrauterine insemination (IUI)
  • In-vitro fertilization (IVF)
    • Classical/standard IVF
    • Intracytoplasmic sperm injection (ICSI)
  • Others

Market, By Age Group

  • Below 35 years
  • 35-37 years
  • 38 – 39 years
  • 40-42 years
  • 43-44 years
  • Over 44 years

Market, By Service Provider

  • Hospitals
  • Fertility clinics
  • Others

IVIRMA, Circle Surrogacy, Nova and New Hope Fertility Clinic among various others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF